MyAverix Finance
SA · Healthcare
BIONTECH SE DRN (B1NT34)
Biotechnology
BIONTECH SE DRN (B1NT34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $112.02B, P/E ratio is 18.00, net margin is -39.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for B1NT34
BIONTECH SE DRN (B1NT34) — FAQ
What is BIONTECH SE DRN's market cap?
BIONTECH SE DRN (B1NT34) has a reported market cap of $112.02B (data as of 2026-03-29).
What is B1NT34's P/E ratio?
The price-to-earnings (P/E) ratio for BIONTECH SE DRN (B1NT34) is 18.00 (data as of 2026-03-29).
Does BIONTECH SE DRN pay a dividend?
Dividend yield is not available in the current snapshot for BIONTECH SE DRN (B1NT34). Check the MyAverix Finance app for the latest dividend data.
What sector is BIONTECH SE DRN in?
BIONTECH SE DRN (B1NT34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is B1NT34 listed on?
B1NT34 is listed on SA.
What is BIONTECH SE DRN's net margin?
BIONTECH SE DRN (B1NT34) reports a net margin of -39.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.